Cladis Investment Advisory LLC Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Cladis Investment Advisory LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 84.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,407 shares of the healthcare conglomerate’s stock after purchasing an additional 2,021 shares during the period. Cladis Investment Advisory LLC’s holdings in UnitedHealth Group were worth $1,522,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the stock. Black Swift Group LLC bought a new stake in UnitedHealth Group in the third quarter worth about $4,420,000. Natixis Advisors LLC increased its stake in shares of UnitedHealth Group by 69.8% during the 3rd quarter. Natixis Advisors LLC now owns 734,798 shares of the healthcare conglomerate’s stock worth $253,726,000 after purchasing an additional 302,113 shares during the last quarter. Bowie Capital Management LLC lifted its stake in UnitedHealth Group by 9.0% in the third quarter. Bowie Capital Management LLC now owns 265,051 shares of the healthcare conglomerate’s stock valued at $91,522,000 after purchasing an additional 21,824 shares during the last quarter. Korea Investment CORP increased its position in UnitedHealth Group by 2.4% in the third quarter. Korea Investment CORP now owns 658,229 shares of the healthcare conglomerate’s stock worth $227,286,000 after buying an additional 15,298 shares during the last quarter. Finally, Rhenman & Partners Asset Management AB lifted its position in shares of UnitedHealth Group by 105.5% during the 3rd quarter. Rhenman & Partners Asset Management AB now owns 62,530 shares of the healthcare conglomerate’s stock valued at $21,592,000 after buying an additional 32,100 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Jefferies Financial Group dropped their price target on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Finally, UBS Group cut their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Trading Down 0.7%

Shares of UNH stock opened at $286.86 on Friday. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The firm has a market cap of $260.38 billion, a P/E ratio of 21.75, a price-to-earnings-growth ratio of 1.32 and a beta of 0.41. The business has a 50-day moving average price of $308.28 and a two-hundred day moving average price of $325.83. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same quarter in the previous year, the company posted $6.81 EPS. UnitedHealth Group’s quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Monday, March 9th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 3.1%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.